http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113694030-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73275bf7ba679addf85010f4111c0c90
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77fdc4d89aab1a6470b1d84c4afdf157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cb6e5a4fa755b8865c0946eda2df15e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a69a1c1e19007b1303cc328ddbbdc140
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0adc37c9860fd17619b8575d0cdd27a6
publicationDate 2021-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113694030-A
titleOfInvention Preparation method of bortezomib freeze-dried powder for injection
abstract The invention provides a freeze-drying process for preparing bortezomib for injection, which is characterized in that bortezomib liquid medicine is subpackaged and then freeze-dried, and the primary drying stage is characterized in that: heating the plate layer to-20 ℃, and maintaining the pressure of 50-60Pa for 15-18 h; and then, the temperature of the plate layer is unchanged, the pressure is adjusted to be 80-90 Pa, and the pressure is maintained for 8-12 h. The bortezomib for injection prepared by the process has the advantages of no spray bottle, full and complete appearance, content meeting the requirement, improved stability of product content, improved drying efficiency, shortened freeze-drying time, and suitability for industrial production.
priorityDate 2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431904250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6386

Total number of triples: 42.